Risk prediction tools for cancer in primary care

British Journal of Cancer

Volumn 113, Issue 12, 2015, Pages 1645-1650

  Usher Smith, Juliet ^a   Emery, Jon ^b   Hamilton, Willie ^c   Griffin, Simon J ^a   Walter, Fiona M ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF EXETER   (United Kingdom)

Author keywords

cancer; diagnosis; model; prediction; Primary care; risk; screening

Indexed keywords

ALCOHOL CONSUMPTION; BEHAVIOR CHANGE; BREAST CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; CARDIOVASCULAR RISK; CLINICAL DECISION MAKING; CLINICAL PRACTICE; COLORECTAL CANCER; COST EFFECTIVENESS ANALYSIS; FAMILY HISTORY; GENETIC RISK; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HEART DISEASE; HIGH RISK POPULATION; HUMAN; LUNG CANCER; MELANOMA; NATIONAL HEALTH ORGANIZATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ACTIVITY; PREDICTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; SMOKING; UNCERTAINTY; DECISION MAKING; NEOPLASMS;

DECISION MAKING; HUMANS; NEOPLASMS; RISK ASSESSMENT; UNCERTAINTY;

EID: 84952639829     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2015.409     Document Type: Review

References (30)

1. Brindle P, Beswick A, Fahey T, Ebrahim S (2006) Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review. Heart 92: 1752-1759.
2. Chiang PP-C, Glance D, Walker J, Walter FM, Emery JD (2015) Implementing a QCancer risk tool into general practice consultations: an exploratory study using simulated consultations with Australian general practitioners. Br J Cancer 112: S77-S83.
3. Chowdhury S, Dent T, Pashayan N, Hall A, Lyratzopoulos G, Hallowell N, Hall P, Pharoah P, Burton H (2013) Incorporating genomics into breast and prostate cancer screening: assessing the implications. Genet Med 15: 423-432.
4. Claus EB, Risch N, Thompson WD (1991) Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet 48: 232-242.
5. Colditz G A, Atwood KA, Emmons K, Monson RR, Willett WC, Trichopoulos D, Hunter DJ (2000) Harvard report on cancer prevention volume 4: Harvard Cancer Risk Index. Risk Index Working Group, Harvard Center for Cancer Prevention. Cancer Causes Control 11: 477-488.
6. Collins GS, Altman DG (2013) Identifying patients with undetected pancreatic cancer in primary care: an independent and external validation of QCancer(s) (Pancreas). Br J Gen Pract 63: e636-e642.
7. Collins GS, Reitsma JB, Altman DG, Moons KGM (2015) Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement. Ann Intern Med 162: 55-63.
8. Dikomitis L, Green T, Macleod U (2015) Embedding electronic decisionsupport tools for suspected cancer in primary care: a qualitative study of GPs' experiences. Prim Health Care Res Dev 3: 1-8.
9. Emery J, Morris H, Goodchild R, Fanshawe T, Prevost AT, Bobrow M, Kinmonth AL (2007) The GRAIDS Trial: a cluster randomised controlled trial of computer decision support for the management of familial cancer risk in primary care. Br J Cancer 97: 486-493.
10. Green T, Martins T, Hamilton W, Rubin G, Elliott K, Macleod U (2014) Exploring GPs' experiences of using diagnostic tools for cancer: a qualitative study in primary care. Fam Pract 32: 101-105.
11. Hamilton W (2009) The CAPER studies: five case-control studies aimed at identifying and quantifying the risk of cancer in symptomatic primary care patients. Br J Cancer 101 Suppl: S80-S86.
12. Hamilton W, Green T, Martins T, Elliott K, Rubin G, Macleod U (2013) Evaluation of risk assessment tools for suspected cancer in general practice: a cohort study. Br J Gen Pract 63: e30-e36.
13. Hippisley-Cox J, Coupland C (2015) Development and validation of risk prediction algorithms to estimate future risk of common cancers in men and women: prospective cohort study. BMJ Open 5: e007825.
14. Kurz-Milcke E, Gigerenzer G, Martignon L (2008) Transparency in risk communication: graphical and analog tools. Ann N Y Acad Sci 1128: 18-28.
15. Li K, Hüsing A, Sookthai D, Bergmann M, Boeing H, Becker N, Kaaks R (2015) Selecting high-risk individuals for lung cancer screening-a prospective evaluation of existing risk models and eligibility criteria in the German EPIC cohort. Cancer Prev Res (Phila) 8: 777-785.
16. Louie KS, Seigneurin A, Cathcart P, Sasieni P (2014) Do prostate cancer risk models improve the predictive accuracy of PSA screening A metaanalysis. Ann Oncol 26: 848-864.
17. Marshall T, Lancashire R, Sharp D, Peters TJ, Cheng KK, Hamilton W (2011) The diagnostic performance of scoring systems to identify symptomatic colorectal cancer compared to current referral guidance. Gut 60: 1242-1248.
18. Marteau TM, French DP, Griffin SJ, Prevost AT, Sutton S, Watkinson C, Attwood S, Hollands GJ (2010) Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours. Cochrane Database Syst Rev CD007275.
19. Meads C, Ahmed I, Riley RD (2012) A systematic review of breast cancer incidence risk prediction models with meta-analysis of their performance. Breast Cancer Res Treat 132: 365-377.
20. Müller-Riemenschneider F, Holmberg C, Rieckmann N, Kliems H, Rufer V, Müller-Nordhorn J, Willich SN (2010) Barriers to routine risk-score use for healthy primary care patients: survey and qualitative study. Arch Intern Med 170: 719-724.
21. National Cancer Institute (2006) The nation's investment in cancer research. A plan and budget proposal for the fiscal year 2006.
22. Ruffin MT, Nease DE, Sen A, Pace WD, Wang C, Acheson LS, Rubinstein WS, O'Neill S, Gramling R (2011) Effect of preventive messages tailored to family history on health behaviors: the Family Healthware Impact Trial. Ann Fam Med 9: 3-11.
23. Schroy PC, Emmons KM, Peters E, Glick JT, Robinson PA, Lydotes MA, MylvaganamSR, Coe AM, Chen CA, Chaisson CE, PignoneMP, ProutMN, Davidson PK, Heeren TC (2012) Aid-assisted decision making and colorectal cancer screening: a randomized controlled trial. Am J Prev Med 43: 573-583.
24. Selvachandran SN, Hodder RJ, Ballal MS, Jones P, Cade D (2002) Prediction of colorectal cancer by a patient consultation questionnaire and scoring system: a prospective study. Lancet 360: 278-283.
25. Van Steenkiste B, Van Der Weijden T, Stoffers HE, Grol R (2004) Barriers to implementing cardiovascular risk tables in routine general practice. Scand J Prim Health Care 22: 32-37.
26. Steyerberg EW, Moons KGM, Van Der Windt DA, Hayden JA, Perel P, Schroter S, Riley RD, Hemingway H, Altman DG, Group P (2013) Prognosis Research Strategy (PROGRESS) 3 : prognostic model research. PLoS Med 10: e1001381.
27. Usher-Smith JA, Emery J, Kassianos AP, Walter FM (2014) Risk prediction models for melanoma: a systematic review. Cancer Epidemiol Biomarkers Prev 23: 1450-1463.
28. Waldron C-A, van der Weijden T, Ludt S, Gallacher J, Elwyn G (2011) What are effective strategies to communicate cardiovascular risk information to patients A systematic review. Patient Educ Couns 82: 169-181.
29. Walker J, Licqurish S, Chiang P, Pirotta M, Emery J (2015) Cancer risk assessment tools in primary care: a systematic review of randomised controlled trials. Ann Fam Med. 13: 480-489.
30. Win AK, Macinnis RJ, Hopper JL, Jenkins MA (2012) Risk prediction models for colorectal cancer: a review. Cancer Epidemiol Biomarkers Prev 21: 398-410.